US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent

By Jamie Lennox · February 28, 2024, 7:51 PM GMT

A Korean medical tech company has asked a London court to block Dexcom's bid to tweak its diabetes management patent to avoid losing protections should the court rule that it's invalid....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

4 Benefits Policy Issues To Watch In 2026's 2nd Half No Photo Available

Kellie Mejdrich

The U.S. Department of Labor's work to finalize a 401(k) investment selection safe harbor and plans for a new mental health parity rul... (more story)

Biggest Rulings For Patent Attys In 2026: A Midyear Report No Photo Available

Dani Kass

The U.S. Supreme Court clarified the pleading standard for induced infringement of skinny labels, and the Federal Circuit opened the d... (more story)

AI Notetakers For Doctors Raise 'Bycatching' Liability Risks No Photo Available

Mark Payne

Busy doctors have embraced AI-powered devices that record patient conversations and generate visit notes. The expansion of ambient not... (more story)